Physical activity associated with lower risk of death in patients with diabetes

August 06, 2012

CHICAGO - Higher levels of physical activity were related to lower risk of death in patients with diabetes, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

Increased physical activity (PA) has long been considered a key element in diabetes management. Patients with diabetes are at higher risk for cardiovascular disease (CVD) and premature death, so researchers note it is important to determine whether PA can produce similar beneficial effects in this high-risk population. While other studies have suggested that higher PA levels were associated with reduced CVD and total mortality rates, conclusive high-level evidence is lacking, according to the study background.

Diewertje Sluik, M.Sc., of the German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany, and colleagues sought to investigate whether PA (total, leisure time and walking) was associated with CVD and total mortality in a large group of patients with diabetes as part of a prospective cohort study and meta-analysis. The study included a group of 5,859 patients with diabetes at baseline defined in the EPIC (European Prospective Investigation Into Cancer and Nutrition) study. The meta-analysis included 12 studies.

"In this prospective analysis and meta-analysis of individuals with diabetes, higher levels of total PA, leisure-time PA and walking were associated with a lower risk of total and CVD mortality," the authors comment. "In the prospective analysis, people who reported being moderately physically active had lower mortality risk compared with those who reported being physically inactive."

Compared with patients who were physically inactive, the lowest mortality risk was seen in moderately active persons (hazard ratios [HR] were 0.62 for total mortality and 0.51 for CVD mortality). Leisure-time PA (including cycling, gardening and household work) was associated with lower total mortality risk, and walking was linked to lower CVD mortality risk, according to the study results.

"In conclusion, evidence from the present study and from previous studies summarized by meta-analyses supports the widely held view that PA is beneficially associated with lower mortality in people with diabetes," the authors comment. "Also, because not many patients with diabetes adhere to this advice, future research should elucidate the determinants of physical inactivity and design successful strategies to promote active lifestyles."

(Arch Intern Med. Published online August 6, 2012. doi:10.1001/archinternmed.2012.3130. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The study was supported by a European Foundation for the Study of Diabetes/sanofi-aventis grant. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Writing More Specific Exercise Prescriptions for Patients

In an editorial, Mitchell H. Katz, M.D., of the Los Angeles County Department of Health Services, writes: "As physicians, it is important to understand the different physiologic effects and benefits of different forms of exercise so that we can guide our patients to the best regimen for them."

"A detailed guide for physicians on how to write an exercise prescription is available on the web. Some might question whether providing exercise prescriptions is really the job of the practicing physician, a fair question given that we are all trying to do more in our 15-minute visits," Katz continues.

"But having read the meta-analysis by Sluik at al, I cannot help but note that none of the time I spend trying to decide whether to increase the dose or add a new medication for my patients with type 2 diabetes is likely to result in a 38 percent reduction in all-cause mortality," Katz concludes.

(Arch Intern Med. Published online August 6, 2012. doi:10.1001/archinternmed.2012.3196. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
To contact Diewertje Sluik, M.Sc., email Diewertje.Sluik@dife.de. To contact editorial author Mitchell H. Katz, M.D., call Michael Wilson at 213-240-8059 or e-mail micwilson@dhs.lacounty.gov.

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.